Why the study?
Patients receive multiple drugs during the perioperative period that may interact and impact treatment efficacy and safety, potentially increasing toxicity and perioperative complications.
Design
Review
This is the authors' abstract. We don't add key points for this paper.
In this review, we aim to discuss current information on drug interactions in the perioperative period. During this period, patients receive several drugs that may interact with each other and affect the efficacy and safety of the treatment. There are three types of drug interactions: pharmacodynamic, pharmacokinetic, and pharmaceutical. It is important to recognize that drug interactions may increase the toxicity of the drug or reduce its efficacy, increasing the risk of complications in the perioperative period. This review describes the most commonly used perioperative drugs approved by the FDA and some of the described interactions between them. Thoroughly reviewing a patient's medication list and identifying potential interactions are essential steps in minimizing risks. Additionally, vigilant monitoring of patients during and after surgery plays a pivotal role in early detection of any signs of drug interactions. This article emphasizes the significance of addressing DDIs in the perioperative period to ensure patient well-being and advocates for the implementation of careful monitoring protocols to promptly identify and manage potential interactions.
Answers are grounded in this paper and cite their sources.
Essential to recognize perioperative drug interactions for safety; extends prior synthesis but leaves open prospective validation studies.
No takes yet. Share an insight, caveat, or question.
Silva et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: